Adeza Biomedical Launches the E-tegrity Test, a New Test that Can Lead to Improved Pregnancy Success Rates.SUNNYVALE, Calif.--(BW HealthWire)--Oct. 20, 1997--Adeza Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. launched in the U.S. a novel diagnostic tool to assess the likelihood of embryo implantation at the American Society for Reproductive Medicine annual meeting in Cincinnati. The E-tegrity(SM) Test is available through Adeza's CLIA-certified and State of California-licensed clinical laboratory, Adeza Diagnostic Services diagnostic services, n.pl the imaging and laboratory capabilities available for determining the cause of an illness. . The E-tegrity Test will be launched worldwide on January 1, 1998. Infertility affects approximately 3.1 million couples. It is estimated that 15% to 20% of females undergoing evaluation for infertility have no cause identified for their failure to conceive; uncertainty about the underlying reasons for the infertility often leads to empirical treatment strategies that can create significant psychological and financial burdens. It appears that some women with unexplained infertility may have biochemical alterations affecting uterine function that can now be detected using the E-tegrity Test. The E-tegrity Test detects the B-3 integrin integrin /in·te·grin/ (in´te-grin) any of a family of heterodimeric cell adhesion receptors, each consisting of an a and a ß polypetide chain, that mediate cell-to-cell and cell-to–extracellular matrix interactions. protein and requires tissue from the fundus fundus /fun·dus/ (fun´dus) pl. fun´di [L.] the bottom or base of anything; the bottom or base of an organ, or the part of a hollow organ farthest from its mouth. of the uterus collected through a standard endometrial biopsy technique. The result of the E-tegrity Test is determined through a special staining technique combined with histologic dating of the endometrium endometrium /en·do·me·tri·um/ (-me´tre-um) pl. endome´tria the mucous membrane lining the uterus. en·do·me·tri·um n. pl. . Results are available in less than 14 days of receipt of a properly collected specimen and are sent directly to the ordering physician. Test results from the E-tegrity Test should always be interpreted in conjunction with information available from the clinical evaluation of the patient and other diagnostic procedures to properly assess the patient and assure appropriate patient management. Adeza Biomedical Corp. is a Sunnyvale-based biotechnology company that develops, manufactures and markets biomedical products and services specifically for women's pregnancy and reproductive health care problems including premature and late birth, infertility endometriosis endometriosis (ĕn'dəmē'trē-ō`sĭs), a condition in which small pieces of the endometrium (the lining of the uterus) migrate to other places in the pelvic area. and preeclampsia preeclampsia /pre·eclamp·sia/ (pre?e-klamp´se-ah) a toxemia of late pregnancy, characterized by hypertension, proteinuria, and edema. pre·e·clamp·si·a n. . CONTACT: Adeza Biomedical Corp. Marian E. Sacco, 408/745-0975 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion